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Activation of cyclin B1–cyclin-dependent kinase 1 (Cdk1), triggered by a positive feedback loop at the end of G2, is the
key event that initiates mitotic entry. In metaphase, anaphase-promoting complex/cyclosome–dependent destruction
of cyclin B1 inactivates Cdk1 again, allowing mitotic exit and cell division. Several models describe Cdk1 activation
kinetics in mitosis, but experimental data on how the activation proceeds in mitotic cells have largely been lacking. We
use a novel approach to determine the temporal development of cyclin B1–Cdk1 activity in single cells. By quantifying
both dephosphorylation of Cdk1 and phosphorylation of the Cdk1 target anaphase-promoting complex/cyclosome 3,
we disclose how cyclin B1–Cdk1 continues to be activated after centrosome separation. Importantly, we discovered
that cytoplasmic cyclin B1–Cdk1 activity can be maintained even when cyclin B1 translocates to the nucleus in
prophase. These experimental data are fitted into a model describing cyclin B1–Cdk1 activation in human cells,
revealing a striking resemblance to a bistable circuit. In line with the observed kinetics, cyclin B1–Cdk1 levels required
to enter mitosis are lower than the amount of cyclin B1–Cdk1 needed for mitotic progression. We propose that
gradually increasing cyclin B1–Cdk1 activity after centrosome separation is critical to coordinate mitotic progression.
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Introduction
Mitotic entry is catalyzed by the kinase activity of cyclin-
dependent kinase 1 (Cdk1) in complex with cyclin B1 [1].
Cyclin B1 levels ﬁrst rise during G2 phase, which allows the
accumulation of cyclin B1–Cdk1 complexes [2]. At this stage,
cyclin B1–bound Cdk1 is kept inactive by phosphorylation of
T14 and Y15 by Wee and Myt kinases [3,4]. Subsequently,
cyclin B1–Cdk1 can be activated by Cdc25 phosphatases [5].
They dephosphorylate Cdk1 in two separate binding steps, in
which T14 is dephosphorylated before Y15 [6,7]. In inter-
phase Xenopus egg extracts, cyclin B1–Cdk1 complexes have
low activity. Cdk1 activity in cyclin B1 immunoprecipitates
rises gradually through G2, eventually reaching approxi-
mately 30% of its maximum activity at the end of G2 [8–10].
At this point, a threshold concentration is reached that
autocatalyzes rapid further activation of cyclin B1–Cdk1 and
triggers entry into mitosis [10].
Cyclin B1–Cdk1 activation contributes to the separation of
centrosomes in late G2 [11,12]. In human cells, active cyclin
B1–Cdk1 is initially detected on centrosomes, shortly before
they start to migrate apart at the end of G2 or in prophase
[13,14]. Active cyclin B1–Cdk1 is then phosphorylated on its
cytoplasmic retention sequence, leading to nuclear trans-
location of cyclin B1–Cdk1 and, subsequently, to enhanced
chromosome condensation and nuclear envelope breakdown
[15,16]. When cells are in mitosis, the paired sister chromatids
need to be correctly connected to the mitotic spindle, a
process that is governed by the spindle checkpoint. This
checkpoint inhibits ubiquitin ligase activity of the anaphase-
promoting complex/cyclosome (APC/C), thereby preventing
premature cyclin B1 destruction and Cdk1 inactivation. The
sustained high cyclin B1–Cdk1 activity allows cells to stay in
mitosis as long as is required for all chromosomes to attach to
the mitotic spindle in a bioriented fashion [17,18]. After
requirements for the checkpoint have been met, progressive
loss of cyclin B1–Cdk1 activity is essential for successful
chromosome segregation and completion of cell division [17].
It has been proposed that such a cyclin B1–Cdk1–APC/C
module could function as an autonomous oscillator govern-
ing cell cycle progression [19–21]. Based on the ability of
cyclin B1–Cdk1 to inhibit its inhibitor Wee1 [22–25], to
activate its activators of the Cdc25 phosphatase family [26,27],
and to stimulate cyclin B1 destruction [28], two major
theories of mitotic cyclin–cyclin-dependent kinase (Cdk)
activation have been proposed (see Text S1 and Figure S1
for additional information on these models). Some models
suggest a limit cycle behavior, in which the levels of Cdk
activity will never be stable but oscillate between an inactive
and an active state [19,29,30]. Other models describe a
bistable system, in which thresholds for activation and
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PLoS BIOLOGYinactivation differ and Cdk1 is either inactive, active, or
approaching one of these stable states [31–33]. One of the
differences between these systems is that, in a bistable system,
once a threshold level of cyclin B1–Cdk1 complexes is
reached and activation has proceeded, cyclin B1–Cdk1 will
not be inactivated even though the cyclin B1–Cdk1 levels are
reduced to levels below the activation threshold. This feature
of a bistable system is referred to as hysteresis. A commitment
of cells to start and complete mitosis once they have activated
cyclin B1–Cdk1, is strikingly reminiscent of certain features
of bistability. Various models and some experimental data
indeed point to bistability governing mitotic Cdk1 activation
[34–36] (Figure S1). It has also been argued, however, that the
experimental set-ups used so far may have created an
artiﬁcial bistable system [29]. Furthermore, recently, Csi-
kasz-Nagy and coworkers [37] suggested that both bistability
and limit cycle oscillations occur, depending on the cellular
context.
Although it is clear that cyclin B1–Cdk1 is mostly inactive
in G2 and highly active in mitosis, methods to follow the
development of cyclin B1–Cdk1 activity during the rapidly
successive mitotic stages have been lacking. As a result,
experimental data of Cdk1 activation kinetics in human cells
are very limited. Such data could, for instance, reveal whether
cyclin B1–Cdk1 activation, once initiated, is sufﬁciently
robust to drive mitotic progression even in the cytoplasm,
when a large fraction of cyclin B1–Cdk1 translocates to the
nucleus in prophase. This would be indicative of a bistable
Cdk1 activation response and further indicate that precise
regulation of cyclin B1–Cdk1 activity could control mitotic
events per se.
We use novel assays to determine how cytoplasmic cyclin
B1–Cdk1 activation proceeds in human cells. We ﬁnd that
cyclin B1–Cdk1 is activated in late G2 and that the activity
gradually increases between centrosome separation and
prometaphase. Moreover, we investigated the effect of
partially reducing Cdk1 levels on mitotic progression. We
show that whereas low levels of Cdk1 are sufﬁcient for mitotic
entry, higher levels are needed for normal mitotic progres-
sion and initiation of anaphase. Altogether, we show that the
development of cyclin B1–Cdk1 activity in vivo proceeds as if
it were governed by bistability. Our results explain how cyclin
B1–Cdk1 can be responsible for cytoplasmic rearrangements
even during nuclear translocation. We propose a model in
which different thresholds of cyclin B1–Cdk1 activity, in
combination with a gradual increase in activity, help to
coordinate early and late mitotic events.
Results/Discussion
Temporal Development of Cyclin B1–Cdk1 Activity in
Single Cells
Cyclin B1–Cdk1 is initially activated on centrosomes in late
G2, shortly before they start to migrate apart [13,14]. To
determine how cyclin B1–Cdk1 activation proceeds, we
developed an assay to follow the pattern of cyclin B1–Cdk1
activity in single human cells. Because Cdk1 levels are in
excess of cyclin levels in mammalian cells [38] (unpublished
data) and because Cdk1 is phosphorylated only when in
complex with a cyclin [10], we reasoned that the ratio
between phosphorylated Cdk1 and cyclin B1 could provide
an estimate of the relative activity of the cyclin B1–Cdk1
complex. Therefore, we used an antibody recognizing Cdk1
when phosphorylated on Y15 (Cdk1 phosphorylation [Cdk1-
P], which represents inactive Cdk1) combined with an
antibody recognizing cyclin B1, in immunoﬂuorescence
experiments.
We ﬁrst wanted to test the speciﬁcity of these antibodies,
and therefore we used short hairpin RNA (shRNA) to reduce
the levels of cyclin B1 or Cdk1 in cells. The cytoplasmic
staining of the Cdk1-P antibody in G2 almost completely
disappeared by microinjecting cells with an shRNA to cyclin
B1 or Cdk1, showing the cytoplasmic signal represents
phosphorylated Cdk1 (Figure S2). However, Cdk1 RNA
interference (RNAi) could not totally eliminate the staining
in interphase nuclei and on centrosomes, indicating some
cross-reactivity in these locations, most probably with
phosphorylated Cdk2. Furthermore, the cyclin B1 and
Cdk1-P signal colocalized linearly in the cytoplasm, indicat-
ing that the signal represents cyclin B1–Cdk1 complexes
(Figure S2). Therefore, in this study we exclusively focused on
cytoplasmic cyclin B1–Cdk1 activation, which we could
monitor speciﬁcally.
Figure 1 shows maximum intensity projections of cells in
various stages of G2 and mitosis, costained for chromosomes,
phospho-Cdk1, and cyclin B1. In G2 and mitotic cells, cyclin
B1, shown in the second panel, colocalized with cytoplasmic
phospho-Cdk1, apparently decreasing around the time when
cyclin B1 (third panel) translocated to the nucleus. In
metaphase, cyclin B1 levels declined, whereas Cdk1-P
appeared to remain similar to the level in prometaphase
cells. In anaphase, both cyclin B1 and phospho-Cdk1 levels
had largely disappeared.
Subsequently, we analyzed numerous undeconconvolved
ﬂuorescent images of G2 and mitotic cells, to carefully
quantify the cytoplasmic cyclin B1 and Cdk1-P staining in
various phases of G2 and mitosis (see Materials and Methods
and Figure S3 for details on image acquisition and data
analyses). To control for changes in morphology during
mitotic progression, we performed quantitations of nuclear
factor jB (NF-jB), a protein that is cytoplasmic in normal
cells and has no obvious function in mitosis (Figure S4). We
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Author Summary
When active, the enzyme cyclin B1–cyclin-dependent kinase 1
(Cdk1) commits a growing cell to the process of mitotic cell division
and chromosome separation. Cyclin B1–Cdk1 activation is controlled
in many ways, but once its activity rises above a certain level, further
activation of cyclin B1–Cdk1 is catalyzed by a positive-feedback
loop. This generates highly active cyclin B1–Cdk1 and triggers the
start of mitosis, which can only be completed when cyclin B1–Cdk1
activity is properly shut off again. However, it is not clear how cyclin
B1–Cdk1 activity develops in human cells or how the switch
between its inactive and active states is controlled. Our work
combines activation measurements with a kinetic model to study
how cyclin B1–Cdk1 activity accumulates just before and during
mitosis. We show that cyclin B1–Cdk1 activity develops gradually in
early mitosis and that different activity levels are required for
initiation of, and progression through, mitosis. We also demonstrate
that once cyclin B1–Cdk1 activation is truly launched, it is bound to
continue and will not lightly drop back again. We propose that the
successive cyclin B1–Cdk1 activity levels by themselves may
coordinate the progression through the distinct phases of mitosis.exclusively analyzed endogenous proteins in unsynchronized
HeLa cells under normal growth conditions.
After correction for changes in morphology, we subse-
quently plotted cytoplasmic Cdk1-P levels as a function of
cytoplasmic cyclin B1 levels. We observed that both Cdk1-P
and cyclin B1 increased in a roughly linear fashion when cells
proceeded through G2, with little change in the Cdk1
phosphorylation (P) state, in agreement with cyclin B1–
Cdk1 complexes displaying low activity in early G2 (Figures 1
and 2A; blue diamonds). As we showed previously [14], a
subset of cells with nonseparated centrosomes and high cyclin
B1 levels contained reduced levels of phosphorylated Cdk1,
indicating a pool of cyclin B1–Cdk1 is partially active. In cells
with high cyclin B1 levels, we saw Cdk1 dephosphorylation
further proceeding when centrosomes started to migrate
apart. The dephosphorylation gradually continued until
chromosomes were aligning in prometaphase (Figures 1 and
2A; top left, red squares and light-blue Xs), whereas total
Cdk1 levels did not decline (Figure S5). This strongly
indicates cyclin B1–Cdk1 activation progressively develops
during mitosis.
Cytoplasmic Cyclin B1–Cdk1 Dephosphorylation
Continues after Nuclear Translocation of Cyclin B1
Subsequently, we focused on the development of cyclin B1–
Cdk1 dephosphorylation when cyclin B1 enters the nucleus
due to phosphorylation of its cytoplasmic retention signal in
prophase [15,39]. It should be noted that the effect of nuclear
translocation on development of cyclin B1–Cdk1 activity is
puzzling. Translocation means a drop in the cytoplasmic
cyclin B1 concentration, which could cause cytoplasmic Cdk1
activity to plummet. However, cytoplasmic cyclin B1–Cdk1
activity seems required to govern mitotic onset in the
cytoplasm, e.g., to induce rearrangements such as micro-
tubule polymerization and spindle assembly, involved in
promoting nuclear envelope breakdown at the end of
prophase [40,41]. In a bistable model, though, a sudden
reduction of cyclin B1 from the cytoplasm at the end of
prophase would not necessarily prevent cytoplasmic activa-
tion of cyclin B1–Cdk1 to proceed (see Text S1 and Figure
S1).
When we compared cyclin B1 and phospho-Cdk1 levels
before and after the onset of translocation (Figure 2A, red
squares and green triangles), we observed that during cyclin
B1 nuclear translocation, both the cytoplasmic cyclin B1– and
Cdk1-P levels continued to decrease (Figures 1 and 2A; also
see statistical analyses of the data in Figures 2C and S7). To
further visualize the details of cyclin B1–Cdk1 dephosphor-
ylation during nuclear translocation, we plotted the nuclear-
to-cytoplasmic cyclin B1 ratio as a function of the ratio
between cytoplasmic Cdk1-P and cyclin B1 in Figure 2B.
When the ratio between phosphorylated Cdk1 and cyclin B1
was approaching 50% of that observed in early G2 cells,
cyclin B1–Cdk1 translocated to the nucleus. Strikingly, in
cells with translocated cyclin B1, the ratio between cytoplas-
mic Cdk1-P and cyclin B1 indeed continued to decrease,
demonstrating the activation did proceed in the cytoplasm,
too (Figure 2B). Thus, our results show that a pool of active
cyclin B1–Cdk1 remains in the cytoplasm even throughout
the nuclear translocation, potentially explaining how cyclin
B1–Cdk1 activity can contribute to mitotic rearrangements
taking place outside the nucleus at this time. Furthermore,
these results indicate that once a positive feedback has been
initiated, the activation of cyclin B1–Cdk1 is remarkably
robust, and even proceeds upon a sudden drop in cyclin B1
concentration of approximately 50% (Figure 2C).
Total cyclin B1–Cdk1 activity in the cytoplasm is depend-
ent on the concentration of the complex as well as on the
fraction of active complexes present. We therefore reasoned
that by multiplying the ‘‘relative activity’’ with the cyclin B1
levels, we would acquire a rough estimate of the ‘‘total cyclin
B1–Cdk1 activity.’’ To estimate the relative activity, we
assumed the ratio between P-Cdk1 and cyclin B1 in early
G2 cells represented inactive complexes (Figures 2D and 2F).
Figure 1. Immunofluorescence Pattern of Cyclin B1 and Y15 Phosphorylated Cdk1 from Early G2 Phase to Anaphase in HeLa Cells
Fluorescence images are undeconvolved maximum intensity projections of unsynchronized cells from a single cover slip. Cells are presented from G2
(left) to anaphase (right). Top row: DNA, second row: phosphorylated Cdk1, third row: cyclin B1, bottom row: merge of all three fluorescence channels.
doi:10.1371/journal.pbio.0050123.g001
PLoS Biology | www.plosbiology.org May 2007 | Volume 5 | Issue 5 | e123 1129
Ongoing Cdk1 Activation Controls MitosisWe then continued to plot the total cytoplasmic cyclin B1–
Cdk1 activity as a function of cytoplasmic cyclin B1 levels,
obtaining a loop representing activation and deactivation in
G2 and mitosis (Figure 2D and 2E). In this representation, we
see that the total cyclin B1–Cdk1 activity starts to increase in
late G2, continues to rise to prometaphase, and remains high
until cyclin B1 levels start to decline by inactivation of the
spindle checkpoint and activation of Cdc20-APC/C in
metaphase. The plot generated by our experimental data
markedly resembled the relationship between in vitro Cdk1
activity and cyclin B concentration, observed in Xenopus egg
extracts [9], with the important difference that human
cytoplasmic cyclin B1 levels decreased as a result of nuclear
translocation in prophase (Figure 2D, 2E, and 2F). Our results
show that the principle of the cell-cycle oscillations between
cyclin-Cdk activation and inactivation thus appears to be
conserved in Xenopus and human cells.
Phosphorylation of a Direct Cyclin B1–Cdk1 Target in
Single Cells
Next, as an independent approach to determine cyclin B1–
Cdk1 activity in human cells, we aimed to extend our analyses
to a direct target of cyclin B1–Cdk1. As an additional beneﬁt,
this would allow us to conﬁrm the kinetics of cyclin B1–Cdk1
activation when quantifying a positive readout signal. To this
end, we used puriﬁed antibodies speciﬁcally recognizing
phosphorylated APC3, a cyclin B1–Cdk1 substrate, in mitosis
[42,43]. Figure S6A clearly shows the accumulation of APC3–
Figure 2. Gradual Dephosphorylation of Cdk1 in Mitotic Entry
(A) Quantification of immunofluorescence labeling. Cytoplasmic Cdk1-P (y-axis) and cyclin B1 signal (x-axis) were quantified in the cytoplasm of
unsynchronized cells. Each dot corresponds to one cell. Cells were labeled according to morphology and staining as follows: cells with cytoplasmic
cyclin B1 (blue diamonds), cytoplasmic cyclin B1 and separated centrosomes (red squares), predominant cyclin B1 staining in nucleus (green triangles),
condensed DNA and no distinguishable nucleus in cyclin B1 staining (light blue Xs), all chromosomes aligned on a metaphase plate (black dots), and
anaphase (red Xs).
(B) Relative cyclin B1–Cdk1-P during nuclear translocation. Ratio of cytoplasmic Cdk1-P and cyclin B1 signal (y-axis) in cells with separated centrosomes
(red squares) and translocated cyclin B1 (green triangles) correlated with the ratio of nuclear and cytoplasmic cyclin B1 (x-axis). The average cytoplasmic
Cdk1-P/cyclin B1 ratio of early G2 cells is defined as 100%. Early G2 cells are defined as cells with cytoplasmic cyclin B1 levels between average anaphase
cyclin B1 levels and lowest cyclin B1 level of cell with separated centrosomes.
(C) Average values of cytoplasmic cyclin B1 and phosphorylated Cdk1. Values are shown as percentage of the highest average. Error bars indicate SD.
Neg, cells used for background subtraction; E G2, G2 cells with cyclin B1 levels between average anaphase levels and lowest value of cell with separated
centrosomes; L G2, G2 cells with cyclin B1 levels above lowest value of cell with separated centrosomes; Sep, separated centrosomes; Tra, translocated
cyclin B1; Pro, prometaphase; Met, metaphase; Ana, anaphase.
(D) Estimated cytoplasmic cyclin B1/Cdk1 activity of individual cells. The degree of dephosphorylation multiplied with the level of cyclin B1 (y-axis), as a
function of the level of cyclin B1 (x-axis). Cells are labeled as in (A).
(E) Average values of estimated cytoplasmic cyclin B1–Cdk1 activities within the distinct phases, shown in Figure 3D, as a function of cytoplasmic cyclin
B1 levels.
(F) Average values of cytoplasmic Cdk1-P/cyclin B1 ratio and estimated cytoplasmic cyclin B1–Cdk1 activities in the different phases. Values are shown
as percentage of the highest average. Error bars indicate SD. Labels are as in Figure 2C.
doi:10.1371/journal.pbio.0050123.g002
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Ongoing Cdk1 Activation Controls MitosisThr244-P on centrosomes after cyclin B1 translocation and
during prometaphase, while the signal stabilized in meta-
phase and was greatly reduced in anaphase. Because
cytoplasmic staining of this epitope was weak, next we
analyzed the appearance of APC3–Thr446-P. Phosphoryla-
tion of this site was ﬁrst identiﬁed in mitotic cells and has
been reported to be induced by Cdk1, but not by Polo-like
kinase 1, in vitro [44]. We saw the emergence of APC3–
Thr446-P when centrosomes separated and cyclin B1 started
to translocate to the nucleus in prophase (Figure S6B). For
comparison, in the same manner as for Cdk1 dephosphor-
ylation, we next quantitated the increase in APC3–Thr446-P
exclusively in the cytoplasm. Figure S6C (gray bars) shows that
cytoplasmic APC3–Thr446-P ﬁrst rose slightly in G2 cells,
slowly increasing after centrosome separation, and, interest-
ingly, continued to accumulate while cyclin B1–Cdk1 trans-
located to the nucleus. Figure 3 shows a similar but more
detailed quantiﬁcation throughout G2 and mitosis of APC3–
Ser426-P, a well-established Cdk1 target in vitro and in vivo,
which is phosphorylated independently of Polo-like kinase 1
in vivo [44]. Accumulation of cytoplasmic APC3–Thr446-P
and APC3–Ser426-P was highly comparable (Figure S6C).
Cdk1-speciﬁc APC3 phosphorylation continued throughout
prometaphase, indicating a need for enhanced cyclin B1–
Cdk1 activity in prometaphase.
It should be noted that whereas the direct measurements in
Figure 2 denote the activity of the cyclin B1–Cdk1 complex
when the cell is ﬁxed, the measurements in Figure 3 represent
the accumulated sum of kinase as well as phosphatase
activities. Moreover, APC3 is situated in both the nucleus
and the cytoplasm, leading to an increased accessibility to
cyclin B1–Cdk1 after nuclear envelope breakdown. There-
fore, the detected APC3 phosphorylation lags slightly behind
the detected Cdk1 dephosphorylation. However, both meas-
urements showed a similar trend in gradually increasing
Figure 3. Gradual Phosphorylation of the Cdk1 Target APC3 S426
(A) Deconvolved maximum projections of unsynchronized HeLa cells. The cell-cycle stage is indicated above the figure. Top row: merge, second row:
DNA, third row: cyclin B1, bottom row, APC3 S426P.
(B) Dot plot of cytoplasmic cyclin B1 and cytoplasmic APC3 S426P staining. Each dot corresponds to one cell. Cells are arranged according to
morphology and staining as in Figure 2A.
(C) Average values of cytoplasmic cyclin B1 and phosphorylated APC3. Values are shown as percentage of the highest average. Error bars indicate SD.
Bars are labeled as in Figure 2C.
doi:10.1371/journal.pbio.0050123.g003
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Ongoing Cdk1 Activation Controls Mitosiscyclin B1–Cdk1 activity, in which the direct activity precedes
the accumulated resulting phosphorylation.
Fitting Activation to Mitotic Events: A Plot of Cyclin B1–
Cdk1 Activation Kinetics
To correlate the duration of Cdk1 activation with mitotic
progression, we determined the timing of speciﬁc G2 and
mitotic events: centrosome movement, DNA condensation,
chromosome congression and sister chromatid separation in
HeLa cells (Figure S8). In late G2, the centrosomes of most
cells migrated from a position next to the nucleus to below
the nucleus, where they separated. The activation of cyclin
B1–Cdk1 preceded centrosome separation, but during the 27
min (SD ¼ 13 min) between centrosome separation and DNA
condensation, almost 50% of the cytoplasmic cyclin B1–Cdk1
complexes were activated (Figure 4, black line). At the same
time, the amount of Ser426-phosphorylated APC3 started to
increase (Figure 4, dotted line). Due to the nuclear trans-
location of cyclin B1–Cdk1, the total cytoplasmic activity was
moderately decreased when DNA condensation became
visible (Figure 4, gray line). We showed in Figure 2 that even
during nuclear translocation, activation of cytoplasmic cyclin
B1–Cdk1 complexes could continue. We also showed that
accumulation of APC3–Ser426-P did not decrease during
nuclear translocation. The chromosomes started to align on
the metaphase plate about 20 min (SD ¼ 9 min) after DNA
condensation was initiated. During this process, cyclin B1–
Cdk1 gained full activity, and as a consequence, the most
dramatic increase in APC phosphorylation occurred.
In conclusion, cyclin B1–Cdk1 activity continued to
accumulate between centrosome separation and chromo-
some congression in HeLa cells during a time span of
approximately 45 min. The dephosphorylation of cyclin B1–
Cdk1 proceeded in a gradual fashion, and the development of
total cytoplasmic activity was modestly inﬂuenced by local-
ization changes of the cyclin B1–Cdk1 complex (Figure 4).
Implications for the Features of a Cdk1–APC/C Cell Cycle
Oscillator
If bistability and hysteresis govern cyclin B1–Cdk1 activity,
Cdk1 should not be phosphorylated and inactivated when the
cyclin B1 concentration drops slightly below the activation
threshold [45]. This occurs twice in an unperturbed cell cycle:
during nuclear translocation of cyclin B1–Cdk1 in late G2,
when cytoplasmic cyclin B1 levels decrease to the level of G2
cells in which cyclin B1–Cdk1 is inactive, and when cyclin B1
starts to be degraded in metaphase (Figures 1, 2D, 2E, and 2F).
Indeed, we do not observe any increase of Cdk1-P during
these events. Although we need to stress that this does not
prove that mitosis is controlled by a bistable cyclin B1–Cdk1
circuit (since the system may not reach a steady state), we
show that within the time-frame in which concentration
changes occur in vivo, the activation curve for human cyclin
B1–Cdk1 proceeds as if it were governed by bistability. It is
probable that this contributes to the robustness and
unidirectionality of mitosis, especially during the dramatic
decrease in cytoplasmic cyclin B1–Cdk1 levels during nuclear
translocation.
In a recent spatial theoretical simulation, Yang and
coworkers [30] found that removing cyclin B1–Cdk1-depend-
ent destruction of cyclin B1 turns the activation dynamics
from limit cycle oscillations to bistability. Interestingly, in this
model the cyclin B1–Cdk1 activity continues to rise in the
cytoplasm during nuclear translocation. It should be noted
that the negative feedback loop, leading to cyclin B1
inactivation, is not directly set off by the active state of
cyclin B1–Cdk1. Rather, active cyclin B1–Cdk1 triggers
mitotic entry, and the mitotic state is maintained by the
spindle checkpoint, which prevents early activation of the
APC/C-dependent negative feedback, even after the APC/C
has already been phosphorylated by cyclin B1–Cdk1. This
means that once cells are in the mitotic state with high cyclin
B1–Cdk1 levels, they can remain in this state even when the
negative feedback has been ‘‘preloaded’’ (i.e., the APC/C is
maximally phosphorylated by cyclin B1–Cdk1). During a
prolonged arrest, cyclin B1–Cdk1 activity remains high for
hours in the checkpoint-arrested, mitotic state. Eventual
slippage through the checkpoint is caused only by progres-
sive, but very slow, degradation of cyclin B1 [46]. In normal
mitotic cells, cyclin B1 is destroyed only when spindle
checkpoint silencing releases inhibition of the APC/C, and
Cdk1 rapidly returns to its low, interphase-state, activity.
Effect on Mitotic Progression by Reducing Cyclin-Cdk1
Activity
Abrupt and efﬁcient Cdk1 activation at the beginning of
mitosis might be required to eventually trigger normal Cdk1
inactivation, which is necessary to build an uncompromised
Cdk1-APC/C cell cycle oscillator in cycling extracts [9].
Figure 4. Schematic Representation of Cytoplasmic cyclin B1–Cdk1
Activation
Average ratio of Cdk1-P and cyclin B1 staining (black solid line), average
estimated cyclin B1–Cdk1 activity (gray solid line), and average APC-3
S426-P (black dotted line) plotted as a function of time (x-axis). The
duration of mitotic events is derived from measurements described in
Figure S8. Note the decrease in total cytoplasmic activity, but not in the
progression of cyclin B1–Cdk1 dephosphorylation, between centrosome
separation and nuclear translocation of cyclin B1–Cdk1.
doi:10.1371/journal.pbio.0050123.g004
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Ongoing Cdk1 Activation Controls MitosisRudner, Hardwick, and Murray reported that a slight
decrease in speciﬁc Saccharomyces cerevisiae Cdk1 activity (by
a mutation rendering active Cdc28 inefﬁcient in ATP
binding, or by mutation of the Cdc28 subunit Cks1) prevented
Cdk-dependent hyperphosphorylation of the APC/C, result-
ing in stabilization of cyclins and Pds1 (S. cerevisiae Securin)
and mitotic arrest [47]. These ﬁndings indicate that speciﬁc
cyclin-Cdk1 kinase activity needs to accumulate during
mitosis to prepare for efﬁcient mitotic exit.
Next, to investigate the requirement for cyclin B1–Cdk1 at
different phases of mitosis in human cells, we reduced the
expression levels of Cdk1 by vector-driven shRNA (Figure
5A). As previously reported [48], we observed that reducing
Cdk1 levels caused an increase in the population of G2 cells
and a reduced fraction of cells entering mitosis after release
from a G1/S block (unpublished data; see also Figure S9).
However, approximately 20% of the cells with reduced Cdk1
levels initiated mitosis. When we compared the levels of Cdk1
in G2 and mitotic cells (collected by shake-off) after Cdk1
RNAi treatment, Cdk1 was selectively more abundant in the
Figure 5. Distinct Requirement of Cdk1 for Mitotic Entry and Mitotic Progression in Human Cells
(A) Cells selected for Cdk1 shRNA expression were synchronized in G2/M by thymidine release; mitotic cells were isolated by gentle shake-off. Mitotic
cells were more than 95% MPM2 positive as analyzed by immunostaining and FACS analysis (unpublished data). Separated G2 and mitotic pools were
analyzed for Cdk1 expression by Western blotting. Cdc20 protein levels serve as loading control. The percentage of remaining Cdk1 protein is indicated
in the figure.
(B) Cells collected by mitotic shake-off were lysed (lanes 1 and 2) or released from nocodazole and incubated in fresh medium for 3 h, recollected, and
lysed (lanes 3 and4). Differences in mitotic phosphorylation shift of APC3 (human Cdc27 ortholog) and Cdc25C, depending on the Cdk1 levels, are
shown (lanes 1 and 2).
(C) The impaired phosphorylation of APC3 in Cdk1-attenuated mitotic cells (lane 1) was rescued by coexpression of a Cdk1-YFP construct containing a
silent mutation in the RNAi targeting region (lane 2). Lane 3 are mitotic cells transfected with a control shRNA, revealing normal endogenous Cdk1
levels.
(D) Distribution of metaphase duration, measured as time between chromosome alignment at the metaphase plate and onset of sister chromatid
separation, in Cdk1 RNAi cells (right) or Cdk1 RNAi cells rescued by coexpression of non–RNAi-sensitive Cdk1-YFP (left).
(E) Time-lapse microscopy analysis of mitotic progression after entry with normal or impaired Cdk1 levels. Bottom panels are consecutive images of
tubulin-YFP in a pS-control cell in mitosis; top panels show delayed chromosome alignment (frames 2 and 3) and stalled metaphase (frames 4–6) after
Cdk1 shRNA.
doi:10.1371/journal.pbio.0050123.g005
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Ongoing Cdk1 Activation Controls Mitosismitotic fraction (Figure 5A). This indicates that only cells
with modestly reduced Cdk1 levels progressed from G2 to
mitosis and suggests the existence of a threshold for Cdk1 at
mitotic entry. These Cdk1-attenuated cells, which initiated
mitosis, clearly showed reduced phosphorylation of the Cdk1
substrates APC3 and Cdc25C when arrested in nocodazole
(Figure 5B), revealing that although the cyclin B1–Cdk1
activity was sufﬁcient for entry into mitosis, phosphorylation
of cyclin B1–Cdk1 targets remained incomplete. Coexpres-
sion of an RNAi-resistant Cdk1 construct together with the
shRNA vector restored APC3 phosphorylation (Figure 5C),
conﬁrming the speciﬁcity of the RNAi. Biochemical analysis
of cyclin B1–Cdk1 activity in cells that entered mitosis with
reduced cyclin B1–Cdk1 levels revealed that the activity per
complex remained largely unchanged, showing that the
remaining cyclin B1–Cdk1 can still be activated even when
total cyclin B1–Cdk1 levels are reduced, a result in agreement
with a model of bistability (Figure S10). Release from
nocodazole arrest revealed that Cdk1-attenuated cells re-
tained the ability to exit from mitosis after 3–4 h (Figure 5B).
However, when analyzed by time-lapse microscopy, cells that
entered mitosis with reduced Cdk1 levels were strongly
delayed before initiation of anaphase, with their chromo-
somes aligned at the metaphase plate (Figures 5D, 5E, and S9;
average of 15 cells: 88 6 65 min compared with 5 6 3 min in
15 control cells, cotransfected with Cdk1 shRNA and RNAi-
resistant Cdk1–yellow ﬂuorescent protein [YFP]). Similar
results were obtained in HeLa cells (unpublished data). Given
the large number of Cdk1 substrates [49], it is likely these
aberrancies can be attributed to impaired function of many
cyclin B1–Cdk1 targets, which prohibited us from pinpoint-
ing a single mitotic process being affected. Nevertheless,
taken together these results indicate that mitotic cyclin B1–
Cdk1 activity needs to further increase after mitotic entry
and pass a threshold before metaphase, necessary to allow
activation of the machinery required for efﬁcient mitotic
progression and initiation of mitotic exit.
An important consequence of our ﬁndings is that distinct
thresholds for cyclin B1–Cdk1 activity exist that control
successive mitotic events. This concept has recently been
demonstrated in mitotic exit, which requires the passage of
different thresholds of decreasing cyclin B1–Cdk1 activity for
the metaphase-to-anaphase and the anaphase-to-telophase
transition [50,51]. Here, we propose a model where the cyclin
B1–Cdk1 activity threshold for mitotic exit exceeds the
threshold for mitotic entry, in line with observations in yeast
[47] (Figure 6). It is tempting to speculate that the gradual
activation of cyclin B1–Cdk1 during early mitosis, and the
passage of distinct thresholds, critically assists in coordinating
early and late mitotic events.
Materials and Methods
Cell culture, RNAi, and Western blots. HeLa and U2OS cells were
cultured in DMEM supplemented with Glutamax, 10% fetal calf
serum, and antibiotics (GIBCO, http://www.invitrogen.com). Double-
stranded oligos encoding shRNAs targeting human Cdk1 or cyclin B1
mRNA were cloned into the pSuper RNAi vector, under control of
the H1 RNA promotor. Speciﬁcity and robustness of knock-down by
various targeting vectors were tested by FACS analyses and Western
blots using mouse anti-Cdk1 for detection, according to described
procedures [52]. In this study, we used pSuper constructs driving
short hairpins to target GGGGATTCAGAAATTGATC of human
Cdk1 or a mixture of two plasmids to target GAACAGCTCTTGGG-
GACAT or GATGCTGCAGCTGGTTGGT of human cyclin B1.
Speciﬁcity and stringency of the shRNA-induced gene knock-down
were rigorously tested for the indicated RNAi experiments by
Western blots, in comparison with unrelated shRNAs and rescue
experiments of Cdk1 shRNA-induced phenotypes.
HeLa or U2OS cells were cotransfected using calcium phosphate
and HBS with 5 or 10 lg of the indicated pSuper constructs, in the
presence of 1 lgo fa-tubulin–pEYFP as a reporter or 1 lg of pBABE-
Puro as a selection marker, per 8-ml culture medium in 9-cm dishes
of subconﬂuent cells or the equivalent for smaller dishes [52]. At 12 h
after transfection, cells were selected with puromycin where
indicated and synchronized in the presence of thymidine. Cells were
released from thymidine block and puromycin selection after 20 h.
Mitotic shake-offs were performed by a single gentle wash with warm
PBS at 12 h after release from thymidine and selection or 14 h after
release and 5 h after the addition of nocodazole (250 ng/ml). For
shRNA-rescue experiments, a YFP-tagged cDNA construct of Cdk1
was generated harboring three silent mutations within the shRNA
targeting regions and cotransfected with the Cdk1 shRNA vector at a
1:10 ratio. At 12 h after thymidine release, cell extracts were prepared
using ELB buffer supplemented with protease and phosphatase
inhibitors. Equalized protein samples were analyzed by Western blots
using mouse anti–cyclin B1 (GNS1), mouse anti-Cdk1 (BD Trans-
duction Laboratories, http://www.bdbiosciences.com), rabbit anti-
Cdc20 (Santa Cruz Biotechnology, http://www.scbt.com), mouse anti-
APC3 (BD Transduction Laboratories), or rabbit anti-Cdc25C (Santa
Cruz).
Time-lapse microscopy. For three-dimensional time-lapse micro-
scopy in Figure S8, see ﬁgure legend. For the analyses of mitotic
progression after depletion of Cdk1, U2OS cells were plated onto
glass-bottomed dishes (Willco Wells, http://www.willcowells.com) and
transfected with 500 ng of pSuper-Cdk1 or control (either empty
pSuper or pSuper targeting human Cks2, which is redundant in
mitosis; R. M. F. Wolthuis, unpublished observations, and [53]), mixed
with 40 ng of a-tubulin–YFP. Cells were transfected with indicated
shRNAs and maintained in a climate-controlled culture chamber at
the stage of a Zeiss Axiovert 200M microscope equipped with a 1.30
NA 340 AxioPlan objective, speciﬁc dual band-pass ﬁlters, a 100-W
xenon fast-shutter excitation device (DG4), and a Roper HQ
Coolsnap CCD camera as shown previously [52]. Acquisition of DIC
and ﬂuorescence images started 40 h after transfection, at 100-ms
Figure 6. Different Cdk1 Activity Thresholds for Mitotic Entry and Mitotic
Exit
Model of relation between Cdk1 activity and mitotic progression. Cells
do not enter mitosis unless a threshold concentration of active cyclin B1–
Cdk1 is present (G2 arrest). After mitotic entry, the Cdk1 activity gradually
increases, which enables the cell to prepare for mitotic exit (normal G2/
M). If the Cdk1 activity does not develop fully after mitotic entry, the cell
is delayed before anaphase (mitotic delay).
doi:10.1371/journal.pbio.0050123.g006
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Morph and PhotoShop software.
Immunoﬂuorescence. Cells were grown on hexametaphosphate/
metasilicate-coated coverslips and ﬁxed with PBS containing 3%
paraformaldehyde and 2% sucrose for 10 min followed by perme-
abilization for 2 min in 20 8C methanol. Cells were incubated for 23
20 min in PBS containing 50 mM ammonium chloride before
blocking in 2% bovine serum albumin and labeled with mouse anti–
cyclin B1 (Santa Cruz, GNS1), rabbit anti-Y15P Cdk1 (Cdk1-P) (Cell
Signaling, http://www.cellsignal.com), mouse anti-Cdk1 (Cell Signal-
ing, POH-1); rabbit anti-phospho APC3-S426, rabbit anti-phospho
APC3-S446 (kindly provided by Jan Michael Peters, IMP, Vienna,
Austria), or rabbit anti-phospho APC3–Thr-244 (Abcam, http://www.
abcam.com). After labeling with Alexa 488 anti-rabbit (Molecular
Probes, http://www.probes.invitrogen.com), Cy3 anti-mouse (Jackson
Immunoresearch, http://www.jacksonimmuno.com), and Hoechst
33342, the coverslip was mounted in Vectashield (Boehringer
Mannheim, http://www.roche.com) or Mowiol 4–88 solution with
antioxidants. z-stacks with 0.2-lm spacing were acquired using a
Deltavision Spectris imaging system equipped with a 360 objective,
NA 1.4. A maximum intensity projection of the z-levels (SoftWorx;
Applied Precision, http://www.api.com) is shown in Figure 1.
Quantiﬁcation of immunoﬂuorescence. Fifteen image z-stacks with
1-lm spacing were acquired in multiple locations of a single
coverslip, using a Deltavision Spectris imaging system equipped with
a320 objective, NA 0.7. To avoid bleaching of antibody ﬂuorescence,
cells were focused using the Hoechst labeling. The images were
corrected for variation in illumination as determined by a photo-
sensor (Applied Precision). For each z-stack, the background signal of
an area without cells was subtracted. z-stacks where the background
Cdk1-P signal differed more than 5% from the average background
signal were not used. The average intensity of a square with ﬁve-pixel
(3.3-lm) side was measured at the z-level that gave the highest average
intensity in the cytoplasm, at a place where no obvious structures
(e.g., centrosome, spindle, strong dotted staining) were present, of 318
cyclin B1–expressing cells using SoftWorx (Applied Precision). For
examples of quantiﬁcation, see Figure S3. The signal from prom-
etaphase, metaphase, and anaphase cells was corrected for morpho-
logical difference by division of the signal by 1.38, as assessed by the
difference in cytoplasmic NF-jB staining between G2 and mitotic
cells Figure S4. The average background signal of cells not expressing
cyclin B1 was quantiﬁed and subtracted from the measurements, with
morphology corrections for prometaphase, metaphase, and anaphase
cells.
Supporting Information
Figure S1. The Concepts of Bistability and Limit Cycle Oscillations
for Cyclin B1–Cdk1 Activation
For details on the ﬁgure, see text S1.
Found at doi:10.1371/journal.pbio.0050123.sg001 (89 KB PDF).
Figure S2. Speciﬁcity of Cdk1-P and Cyclin B1 Antibodies in
Immunoﬂuorescence
HeLa cells were microinjected with 0.005 lg/ll pCFP-Golgi together
with 0.1 lg/ll pS-Cdk1 or pS-cyclin B1, synchronized by a single 24-h
thymidine block and ﬁxed 10–20 h after release. Labeling was
performed as in Figure 1, with the addition of B1:5 guinea pig anti-
Cdc25B [54].
(A) Undeconvolved maximum intensity projections of immunoﬂuor-
escence staining of HeLa cells. Cells with separated centrosomes and
high Cdc25B levels, indicating late G2 phase, are shown. Top,
uninjected cell. Middle, cell injected with pSuper–cyclin B1 and
pCFP-Golgi. Bottom, cell injected with pSuper-Cdk1 and pCFP-Golgi.
All cells were growing on the same coverslip.
(B) Colocalization of the cytoplasmic Cdk1-P and cyclin B1 stainings
of top cell in Figure S2A. Colocalization was assessed with ImageJ
using the plugin Colocalization_ﬁnder. Pixels situated inside mask,
where the relation between the two stainings is linear, are indicated
in white. The Cdk1-P and cyclin B1 stainings thus colocalize linearly
in the cytoplasm, whereas although they colocalize also in the nucleus
and on the centrosomes, part of the staining there comes from
unspeciﬁc signal.
Found at doi:10.1371/journal.pbio.0050123.sg002 (2.3 MB PDF).
Figure S3. Examples of Quantiﬁcation of the Cdk1-P and Cyclin B1
Stainings
Stacks of DNA, cyclin B1, and Cdk1-P stainings were acquired on
multiple locations on a single coverslip. The average intensity of a
square with 3.3-lm side was measured in the cytoplasm at the z-level
that gave the highest cyclin B1 readout. The square was placed so that
visible structures (centrosomes, mitotic spindle, strong dotted
patterns, or dots that may come from secondary antibody precip-
itates) in both the cyclin B1 and Cdk1-P stainings were not included.
Top row. G2 cell. Middle row, late prometaphase cell. Bottom row,
cell with translocated cyclin B1. Note that the middle row measure-
ments are made at a different z-level (as indicated by the z-marker in
the lower left corner of each image).
Found at doi:10.1371/journal.pbio.0050123.sg003 (9.3 MB PDF).
Figure S4. Correction of Quantiﬁcations for Morphology Changes
during Mitosis
(A) The NF-jB staining is cytoplasmic in untreated HeLa cells. Images
are undeconvolved maximum intensity projections of NF-jB, cyclin
B1, and DNA stainings.
(B) Immunoﬂuorescence quantiﬁcations are slightly overestimated in
mitotic cells. The cytoplasmic NF-jB signal was measured at similar
settings as for the quantiﬁcations of cyclin B1 and phosphorylated
Cdk1, as shown in Figure S3. Bars show the average value of the
cytoplasmic NF-jB signal in cyclin B1–positive (G2) and mitotic cells.
Error bars indicate standard deviation. The acquired ratio (1.38) was
used to correct the signal of mitotic cells in all measurements in this
article.
Found at doi:10.1371/journal.pbio.0050123.sg004 (1.0 MB PDF).
Figure S5. Cdk1 Levels Do Not Decrease during Mitosis
(A) Cdk1 levels do not decrease during mitosis. Images show
unsynchronized HeLa cells stained for cyclin B1, Cdk1, and DNA.
(B) Quantiﬁcation of total Cdk1 immunoﬂuorescence labeling.
Cytoplasmic Cdk1 (y-axis) and cyclin B1 signal (x-axis) was quantiﬁed
in the cytoplasm of unsynchronized cells. Each dot corresponds to
one cell. Cells are labeled according to morphology and staining as
follows: G2 cells (blue diamonds), mitotic cells before anaphase (red
squares), anaphase cells (green triangles).
Found at doi:10.1371/journal.pbio.0050123.sg005 (643 KB PDF).
Figure S6. Characterization of APC3 T244P and APC3 S446P
Antibodies throughout Mitosis
(A) APC3 T244 is mainly present on the centrosomes. Images are
maximum intensity projections of deconvolved immunoﬂuorescence
stainings.
(B) APC3 S446 is phosphorylated both in the nucleus and in the
cytoplasm. Images are maximum intensity projections of deconvolved
immunoﬂuorescence stainings.
(C) APC3 S426 and APC3 T446 show similar cytoplasmic phosphor-
ylation patterns. The levels of APC3–S426-P (Figure 3C) and the
estimated cyclin B1–Cdk1 activity (Figure 2F) are included for
comparison. Values are shown as percentage of the highest average.
Error bars indicate standard deviation. Neg, cells used for back-
ground subtraction; E G2, G2 cells with cyclin B1 levels between
average anaphase levels and lowest value of cell with separated
centrosomes; L G2, G2 cells with cyclin B1 levels above lowest value of
cell with separated centrosomes; Sep, separated centrosomes; Tra:
translocated cyclin B1; Pro, prometaphase; Met, metaphase; Ana,
anaphase.
Found at doi:10.1371/journal.pbio.0050123.sg006 (6.4 MB PDF).
Figure S7. Statistical Analysis of Quantiﬁcations in Figures 2F and 3C
The clamp between two bars indicates a statistical difference (p ,
0.05) between the samples. The statistical analysis was performed
using the formula:
X1   X0 6 1.96 3= (S1
2/n1 þ S0
2/n2)
(A) Cytoplasmic ratio of P-Cdk1 and cyclin B1, from Figure 2F.
(B) Cytoplasmic APC3 S426P
Found at doi:10.1371/journal.pbio.0050123.sg007 (491 KB PDF).
Figure S8. Time-frame of Some Mitotic Events in HeLa Cells
HeLa cells growing on a glass-bottom dish (MatTek) were micro-
injected with 0.008 lg/ll YFP-Histone H2B (green) and 0.0016 lg/ll
dsRED-c-tubulin (red). After a 24-h thymidine block, cells were
moved to a Deltavision Spectris microscope (Applied Precision)
equipped with a heater and CO2 chamber (Solent Scientiﬁc). Using a
360 objective, NA 1.4, 15 z-levels with 1-lm spacing were acquired on
multiple locations in the dish every 12 min. The distance between
centrosomes was measured using SoftWorx (Applied Precision). For
ﬁgures, a maximum intensity projection was made of the z-levels.
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Ongoing Cdk1 Activation Controls Mitosis(A) Maximum intensity projections of a cell entering mitosis. The
centrosomes are indicated with arrows.
(B) The average time in minutes, with SD in brackets, between early
mitotic events. Time is counted from the ﬁrst image where the
indicated event is observed. See text for details.
Found at doi:10.1371/journal.pbio.0050123.sg008 (1.9 MB PDF).
Figure S9. Effects of Cdk1 Attenuation on Mitotic Progression
(A) Details of early mitosis revealing delayed spindle formation in
cells entering mitosis with reduced Cdk1 levels.
(B) A cell arresting at the G2-M transition after centrosome
separation. Mitotic entry after centrosome separation usually occurs
within approximately 10–20 min in U2OS cells, e.g., see Figure 5D.
Found at doi:10.1371/journal.pbio.0050123.sg009 (7.0 MB PDF).
Figure S10. Cyclin B1–Cdk1 Complexes from pSuper- or pSuper-
Cdk1–Treated Cells Are Comparably Active
(A) Mitotic U2OS cells were collected after treatment with either
pSuper or pSuper-Cdk1. Extracts of these cells were blotted with
indicated antibodies. Importantly, next to a reduction of Cdk1 levels,
cyclin B1 levels also were reduced. This indicates that only around
40% of cyclin B1–Cdk1 complexes could be formed in pSuper-Cdk1–
treated cells compared to control cells.
(B and C) Cell extracts from (A) were subjected to immunoprecipi-
tation with cyclin B1 antibodies for 4 h at 4 8C. Next, the cyclin B1
immunoprecipitates were incubated with
32P-cATP for 30 min with
Histon H1 as substrate. We separated different amounts of the
reactions on gel to correct for possible differences in cyclin B1 and/or
Cdk1 levels in the IPs. Western blots were performed using cyclin B1
and Cdk1 antibodies after exposures were taken using Phosphor-
Imager ﬁlms. Intensities were measured and background was
subtracted using MetaMorph software and Excel. The highest signal
in the pSuper samples was set at 100%, and the estimated kinase
activity for every lane was plotted against protein levels of cyclin B1
(B) or Cdk1 (C) present in the same lane. In both mitotic samples, the
kinase activity roughly followed the same line. Only the activity per
cyclin B1 molecule from the pSuper-Cdk1 cells seemed slightly lower
(B), which can be explained if cyclin B1 exceeds the remaining
amount of Cdk1. Indeed, correlating kinase activity with the Cdk1
levels revealed a closer overlap (C). All together, these data show that
pS-Cdk1 cells have fewer cyclin B1–Cdk1 complexes but the
complexes that are formed are fully active.
Found at doi:10.1371/journal.pbio.0050123.sg010 (1.2 MB PDF).
Text S1. Small Glossary of Nonlinear Dynamics in the Cell Cycle
Found at doi:10.1371/journal.pbio.0050123.sd001 (21 KB DOC).
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